rs142354133

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2

The NM_014391.3(ANKRD1):​c.347C>T​(p.Thr116Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,567,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T116T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

ANKRD1
NM_014391.3 missense, splice_region

Scores

5
14
Splicing: ADA: 0.9791
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 3.37

Publications

12 publications found
Variant links:
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]
ANKRD1 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD1NM_014391.3 linkc.347C>T p.Thr116Met missense_variant, splice_region_variant Exon 4 of 9 ENST00000371697.4 NP_055206.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD1ENST00000371697.4 linkc.347C>T p.Thr116Met missense_variant, splice_region_variant Exon 4 of 9 1 NM_014391.3 ENSP00000360762.3

Frequencies

GnomAD3 genomes
AF:
0.000183
AC:
24
AN:
131302
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000303
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000245
Gnomad FIN
AF:
0.000111
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000201
Gnomad OTH
AF:
0.000549
GnomAD2 exomes
AF:
0.000146
AC:
36
AN:
245818
AF XY:
0.000150
show subpopulations
Gnomad AFR exome
AF:
0.0000643
Gnomad AMR exome
AF:
0.0000582
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000250
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000124
AC:
178
AN:
1436370
Hom.:
0
Cov.:
30
AF XY:
0.000140
AC XY:
100
AN XY:
715500
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31166
American (AMR)
AF:
0.0000900
AC:
4
AN:
44460
Ashkenazi Jewish (ASJ)
AF:
0.0000386
AC:
1
AN:
25880
East Asian (EAS)
AF:
0.000210
AC:
8
AN:
38154
South Asian (SAS)
AF:
0.0000234
AC:
2
AN:
85426
European-Finnish (FIN)
AF:
0.0000394
AC:
2
AN:
50774
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5668
European-Non Finnish (NFE)
AF:
0.000142
AC:
156
AN:
1095668
Other (OTH)
AF:
0.0000676
AC:
4
AN:
59174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.557
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000183
AC:
24
AN:
131346
Hom.:
0
Cov.:
29
AF XY:
0.000141
AC XY:
9
AN XY:
63712
show subpopulations
African (AFR)
AF:
0.000135
AC:
4
AN:
29638
American (AMR)
AF:
0.000302
AC:
4
AN:
13232
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3358
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4442
South Asian (SAS)
AF:
0.000245
AC:
1
AN:
4076
European-Finnish (FIN)
AF:
0.000111
AC:
1
AN:
9042
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.000201
AC:
13
AN:
64546
Other (OTH)
AF:
0.000545
AC:
1
AN:
1836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000219
Hom.:
0
Bravo
AF:
0.0000982
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000148
AC:
18

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 23, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23572067, 20497191, 19589340, 18273862, 19525294, 32880476) -

Oct 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Sep 09, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Thr116Met variant has been identified at low frequency in various populati ons by the Exome Aggregation Consortium (highest in Europeans; 14/65994 chromoso mes; ExAC, http://exac.broadinstitute.org/; dbSNP rs142354133). This variant has been reported in 1 adult with anomalous pulmonary venous return (TAPVR) and ASD (Cinquetti 2008) as well as 1 adult and one affected relative with DCM (Duboscq -Bidot 2009). In vitro functional studies provide some evidence that the p.Thr11 6Met variant may impact the protein (Cinquetti 2008, Duboscq-Bidot 2009), but th ese types of assays may not accurately represent biological function. In summary , the clinical significance of the p.Thr116Met variant is uncertain. -

ANKRD1-related dilated cardiomyopathy Uncertain:1
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 116 of the ANKRD1 protein (p.Thr116Met). This variant is present in population databases (rs142354133, gnomAD 0.03%). This missense change has been observed in individual(s) with total anomalous pulmonary venous return (TAPVR) and/or dilated cardiomyopathy (DCM) (PMID: 18273862, 19525294, 32880476). ClinVar contains an entry for this variant (Variation ID: 228439). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on ANKRD1 function (PMID: 18273862, 19525294). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Sep 06, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.T116M variant (also known as c.347C>T), located in coding exon 4 of the ANKRD1 gene, results from a C to T substitution at nucleotide position 347. The threonine at codon 116 is replaced by methionine, an amino acid with some similar properties, and is located in the PEST domain. In one study, this alteration was reported in a proband with total anomalous pulmonary venous return, and functional studies showed an increase in the stability of the protein; however the physiological relevance of this finding is unclear (Cinquetti R et al. Hum Mutat. 2008;29(4):468-74). This alteration was reported in a father and son with dilated cardiomyopathy (DCM) (Duboscq-Bidot L et al. Eur Heart J. 2009;30(17):2128-36), and has been reported in additional DCM cohorts (Verdonschot JAJ et al. Circ Genom Precis Med. 2020 10;13(5):476-487) as well as an exome sequencing cohort not selected for the presence of cardiovascular disease; however, details were limited (Norton N et al. Circ Cardiovasc Genet. 2012 Apr;5(2):167-74). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.077
T
BayesDel_noAF
Uncertain
-0.050
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
1.6
L
PhyloP100
3.4
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.26
Sift
Benign
0.12
T
Sift4G
Benign
0.11
T
Polyphen
0.77
P
Vest4
0.41
MVP
0.85
MPC
0.30
ClinPred
0.043
T
GERP RS
5.5
Varity_R
0.066
gMVP
0.35
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.98
dbscSNV1_RF
Pathogenic
0.75
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142354133; hg19: chr10-92678728; API